Evidence map›Paper›PMID 31249951›Full record

ReviewTH open : companion journal to thrombosis and haemostasis2018

Functional Genomics for the Identification of Modulators of Platelet-Dependent Thrombus Formation.

Elien Vermeersch, Benedicte P Nuyttens, Claudia Tersteeg, Katleen Broos, Simon F De Meyer, Karen Vanhoorelbeke, Hans Deckmyn

Open access · goldAbstract readReview
In one paragraph

Review in TH open : companion journal to thrombosis and haemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elien VermeerschLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Benedicte P NuyttensLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Claudia TersteegLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Katleen BroosLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Simon F De MeyerLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Karen VanhoorelbekeLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Hans DeckmynLaboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium.
Research Institute for Chromatography · BEKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the absence of the genome in platelets, transcription profiling provides important insights into platelet function and can help clarify abnormalities in platelet disorders. The Bloodomics Consortium performed whole-genome expression analysis comparing in vitro-differentiated megakaryocytes (MKs) with in vitro-differentiated erythroblasts and different blood cell types. This allowed the identification of genes with upregulated expression in MKs compared with all other cell lineages, among the receptors BAMBI, LRRC32, ESAM, and DCBLD2. In a later correlative analysis of genome-wide platelet RNA expression with interindividual human platelet reactivity, LLRFIP and COMMD7 were additionally identified. A functional genomics approach using morpholino-based silencing in zebrafish identified various roles for all of these selected genes in thrombus formation. In this review, we summarize the role of the six identified genes in zebrafish and discuss how they correlate with subsequently performed mouse experiments.

Indexed as

hemostasisknockout micemegakaryocytesthrombosistransgenic mice

Identifiers

PMID31249951
PMCPMC6524883
OpenAlexW2891033695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.